The initial proteomic analysis indicated that among some of the major signaling pathways known to be key in cancer cells, activated STAT1 and STAT3, were differentially expressed and therefore potentially interesting signaling candidates in resistant cells. The gene discussed is STAT3; the disease is cancer.